[Prevention of the development of drug resistant forms of staphylococci by a combination of antibiotics with DNA-tropic compounds].
D000166:Acridines / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001375:Azaguanine / Q000008:administration & dosage; D002746:Chlorpromazine / Q000008:administration & dosage; D003470:Culture Media; D004269:DNA, Bacterial / Q000494:pharmacology*; D003864:Depression, Chemical; D005419:Flavonoids / Q000008:administration & dosage; D015122:Mercaptopurine / Q000008:administration & dosage; D009154:Mutation / Q000187:drug effects; D009675:Novobiocin / Q000008:administration & dosage; D010403:Penicillin Resistance / Q000187:drug effects*; D010406:Penicillins / Q000008:administration & dosage; D010640:Phenothiazines / Q000008:administration & dosage; D011796:Quinacrine / Q000008:administration & dosage; D013210:Staphylococcus / Q000187:drug effects*; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage
D000166:Acridines; D000900:Anti-Bacterial Agents; D003470:Culture Media; D004269:DNA, Bacterial; D005419:Flavonoids; D010406:Penicillins; D010640:Phenothiazines; D014665:Vasodilator Agents; D009675:Novobiocin; D015122:Mercaptopurine; D011796:Quinacrine; D001375:Azaguanine; D002746:Chlorpromazine
Preduprezhdenie razvitiia lekarstvennoustoĭchivykh form u stafilokokkov kombinatsiiàmi antibiotikov s DNKtropnymi.